|
|
-
United Therapeutics Q1 Earnings Before Non-cash Charges Per Share $2.65 Vs. $2.08 Prior Year
4/25/2013
|
|
|
|
|
|
|
|
|
-
United Therapeutics Receives Second Complete Response Letter For Oral Treprostinil NDA
3/25/2013
|
-
RBC Capital Markets Is Increasing United Therapeutics Corp (UTHR) 4Q13 Estimate To 1.51 From 1.49
2/27/2013
|
-
RBC Capital Markets Is Lowering United Therapeutics Corp (UTHR) 3Q13 Estimate To 1.53 From 1.54
2/27/2013
|
-
RBC Capital Markets Is Increasing United Therapeutics Corp (UTHR) 2Q13 Estimate To 1.47 From 1.46
2/27/2013
|